A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advance Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Kivu Trial Site, Santa Monica, California, United States
Kivu Trial Site, Camperdown, New South Wales, Australia
Kivu Trial Site, Sydney, New South Wales, Australia
Kivu Trial Site, Brisbane, Queensland, Australia
Kivu Trial Site, Adelaide, South Australia, Australia
Kivu Trial Site, Geelong, Victoria, Australia

Study leads

Louie Naumovski, MD, PhD
Study Chair
Kivu Bioscience

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Washington D.C., United States

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

Advance Solid Tumors · Colon and Rectal Cancer · Non - Small Cell Lung Cancer NSCLC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China